04/10/2024
3:15 PM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
4:59 PM | Aprea Therapeutics (Issuer)
Hamill John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
4:57 PM | Aprea Therapeutics (Issuer)
Gilad Oren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:15 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
6:45 AM | Aprea Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/14/2024
7:51 PM | Aprea Therapeutics (Issuer)
Gilad Oren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
7:52 PM | Aprea Therapeutics (Issuer)
HENNEMAN JOHN B III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/14/2024
7:53 PM | Aprea Therapeutics (Issuer)
Seizinger Bernd R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
7:54 PM | Aprea Therapeutics (Issuer)
Hamill John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
3:31 PM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:00 AM | Aprea Therapeutics (Subject)
Sio Capital Management, LLC (Filed by)
| Form SC 13G | |
02/07/2024
5:55 PM | Aprea Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G/A | |
02/06/2024
4:01 PM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2024
11:15 PM | Aprea Therapeutics (Filer)
| Form EFFECT | |
01/26/2024
6:13 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/26/2024
5:03 AM | Aprea Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/04/2024
3:16 PM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
3:20 PM | Aprea Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/16/2023
4:29 PM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/13/2023
6:31 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2023
7:30 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2023
8:50 PM | Aprea Therapeutics (Issuer)
Peters Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
8:51 PM | Aprea Therapeutics (Issuer)
HENNEMAN JOHN B III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
8:51 PM | Aprea Therapeutics (Issuer)
Grissinger Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
8:52 PM | Aprea Therapeutics (Issuer)
Pamukcu Rifat (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
8:45 PM | Aprea Therapeutics (Issuer)
BIZZARI JEAN-PIERRE (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/24/2023
8:47 PM | Aprea Therapeutics (Issuer)
BIZZARI JEAN-PIERRE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
8:48 PM | Aprea Therapeutics (Issuer)
Seizinger Bernd R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
8:50 PM | Aprea Therapeutics (Issuer)
Duey Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
7:00 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
6:36 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
6:39 AM | Aprea Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/11/2023
6:40 AM | Aprea Therapeutics (Filer)
| Form ARS | |
07/11/2023
6:30 AM | Aprea Therapeutics (Filer)
| Form DEF 14A | |
06/08/2023
3:34 PM | Aprea Therapeutics (Issuer)
Seizinger Bernd R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2023
4:16 PM | Aprea Therapeutics (Issuer)
Gruia Gabriela (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/08/2023
4:17 PM | Aprea Therapeutics (Issuer)
Gruia Gabriela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2023
7:45 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
